Arabic Arabic English English French French German German
dark

FDA head calls for inquiry into Alzheimer’s drug review

The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Study model explores impact of police action on population health

Next Post

Dutch reinforce COVID-19 measures after spike in cases

Related Posts
Total
0
Share